Synapse

← RSC Pharmaceutics

Papers in RSC Pharmaceutics

Page 1 · newest first

  1. Development of betaine–aloe vera–gelatin hydrogel formulation for the treatment of burn woundsRSC Pharmaceutics · 2026
  2. A Modelling-based comparison of IVRT and synthetic-membrane permeation for early formulation screeningRSC Pharmaceutics · 2026
  3. The interplay between cationic peptide sequence, siRNA and electrolyte: formulating lipopolyplexes in NaCl solution affords nanocomplexes with exceptional levels of gene silencingRSC Pharmaceutics · 2026
  4. Dual-Adjuvant Mucosal Vaccine Leveraging Mast Cell and TLR9 Agonists for Protection Against Poxvirus InfectionRSC Pharmaceutics · 2026
  5. Nanoparticle Vaccine Formulations for Dengue VirusRSC Pharmaceutics · 2026
  6. Graphene oxide in antibiotic delivery and synergistic antibacterial actionRSC Pharmaceutics · 2026
  7. Design and Development of Niacinamide lipid and polymeric nanoparticles and in vitro permeation studies using human epidermisRSC Pharmaceutics · 2026
  8. Chitosan-coated cobalt ferrite nanocomplexes with dual antimicrobial activity and hemocompatibilityRSC Pharmaceutics · 2026
  9. Controlled delivery of IL-10 and retinoic acid for the treatment of psoriasis using a multilayered microneedleRSC Pharmaceutics · 2026
  10. Dual Cross-linked Biodegradable Polyelectrolyte Hydrogel Actuator for Bi-Directional pH-Responsive Drug ReleaseRSC Pharmaceutics · 2026
  11. Biogenic chitosan anchored Cu ₂ O/ZnO nanocomposite: unlocking synergy for drug delivery, antineoplastic action, and wound repairRSC Pharmaceutics · 2026
  12. Polysaccharide-Based Bioactive Hydrogels for Diabetic Wound ManagementRSC Pharmaceutics · 2026
  13. In vivo translation of a dual-stimuli-responsive drug carrier based on mesoporous silica nanoparticles for the co-delivery of camptothecin and 5-fluorouracilRSC Pharmaceutics · 2026
  14. The role of topical nano-based drug delivery systems for acne treatment: A systematic review and translational insightsRSC Pharmaceutics · 2026
  15. Correction: Enhancing the bioavailability of sparingly-soluble drugs by expandable, solid-solution fibrous dosage formsRSC Pharmaceutics · 2026
  16. Merged in silico-in vitro validations of atenolol and amlodipine besylate with excipient interactions for the design of solid oral dosage formsRSC Pharmaceutics · 2026
  17. Front coverRSC Pharmaceutics · 2026
  18. Inside front coverRSC Pharmaceutics · 2026
  19. Enhancing the performance of granisetron HCl orodispersible tablets using co-processed MCC-mannitol excipients: a direct compression approachRSC Pharmaceutics · 2026
  20. Polymer-lipid hybrid nanoparticles co-encapsulating fucoxanthin and carbon dots for targeted anti-inflammatory therapy in Alzheimer´s diseaseRSC Pharmaceutics · 2026
  21. Needle-Free Transdermal Delivery of mRNA Vaccine with Ionic Liquid Crystals and Effective Tumor Growth InhibitionRSC Pharmaceutics · 2026
  22. Kinetic Modelling and In Vitro Release Mechanism of Levodopa from Sporopollenin-Based Microcapsules in Human Blood PlasmaRSC Pharmaceutics · 2026
  23. SideroGuard: Overview of Siderophore-Enhanced Nanofiber Systems for Biofilm Prevention and ControlRSC Pharmaceutics · 2026
  24. QbD-optimized HA–Pluronic nanomicelles for the targeted repurposing of tofacitinib in breast cancerRSC Pharmaceutics · 2026
  25. nor-MC3 and nor-KC2: Cationic Ionizable Lipids for the Delivery of Therapeutic Nucleic AcidsRSC Pharmaceutics · 2026
  26. Self-nanoemulsifying drug delivery systems (SNEDDS) for treating neglected tropical diseases: affordable and scalable pathways for global health impactRSC Pharmaceutics · 2026
  27. A bioinspired, pH-responsive microsphere matrix of cold-water extracted Colocasia esculenta mucilage and alginate: a new approach for sustained oral delivery of tramadolRSC Pharmaceutics · 2026
  28. Advanced mechanisms of polymer-based drug delivery systems for clinical applicationsRSC Pharmaceutics · 2026
  29. Advancing sustainability through digitalization: from drug development to patient careRSC Pharmaceutics · 2026
  30. Dual centrifugation – a novel perspective on lipid nanoparticle formulation developmentRSC Pharmaceutics · 2026
  31. Redesigning valproic acid therapy in pregnancy: intranasal liposomes for targeted maternal treatmentRSC Pharmaceutics · 2026
  32. Fucoidan/bis-MPA-based dendrimer nanoparticles with intrinsic anti-angiogenic activity for oncology applicationsRSC Pharmaceutics · 2026
  33. Rapid plasma membrane reorganisation and endocytosis in HER2 breast cancer cells incubated with trastuzumab decorated polymer nanoparticlesRSC Pharmaceutics · 2026
  34. Reformulating lumefantrine as Flash NanoPrecipitated particles and the impact of incorporation into milk-based formulations on drug solubilisation during digestionRSC Pharmaceutics · 2026
  35. Lung Physiologically Based Pharmacokinetic Modelling to Predict Sublingual Buprenorphine Kinetics Following Oral InhalationRSC Pharmaceutics · 2026
  36. Overcoming stromal barriers in pancreatic cancer via size-engineered carrier-free nano-prodrugsRSC Pharmaceutics · 2026
  37. QbD Product Development: Rapid Optimization and Scale-Up of PBAE-Based siRNA Delivery via DoE-Guided MicrofluidicsRSC Pharmaceutics · 2026
  38. Advanced bispecific antibody design and inhaled biologics; emerging strategies for asthmaRSC Pharmaceutics · 2026
  39. Polymeric nano-in-microparticles for pulmonary delivery of remdesivir against SARS-CoV-2RSC Pharmaceutics · 2026
  40. Development and Evaluation of Fenticonazole Nitrate Loaded Fucoidan Crafted Lecithin Chitosan Nanoparticles for the Treatment of VaginitisRSC Pharmaceutics · 2026
  41. Simple and Cost-Effective Chrysin-Theophylline Eutectic: Enhanced Solubility, Dissolution, and Oral Bioavailability with Potential for Respiratory ApplicationsRSC Pharmaceutics · 2026
  42. The Paradigm Shift in Therapeutics: A Comprehensive Review of Artificial Intelligence in Drug Delivery SystemsRSC Pharmaceutics · 2026
  43. Extraction, characterization and evaluation of jute ( Corchorus olitorius ) leaf polysaccharide as a binding agent for matrix tablet formulationRSC Pharmaceutics · 2026
  44. Evaluating the role of lactose anomeric composition on tablet disintegration & dissolution: A hidden variable in pharmaceutical formulation.RSC Pharmaceutics · 2026
  45. Recent advances in electrospun nanofiber-based implantable drug delivery systems for breast cancer therapyRSC Pharmaceutics · 2026
  46. Cellulose and its derivatives: understanding physicochemical properties and their applications in pharmaceutical formulationsRSC Pharmaceutics · 2026
  47. Development and application of PEG-based hydrogels by loading Asparagus racemosus -mediated silver nanoparticles for enhancing in vivo wound healing abilitiesRSC Pharmaceutics · 2026
  48. Comparative evaluation of USP II, USP IV, TIM-2, and the dynamic colon model as surrogates for human colonic drug dissolutionRSC Pharmaceutics · 2026
  49. Restoration of tumor suppression and improved anticancer efficacy following nanoparticles-mediated combined anti-miRNA 21 and 5-fluorouracil therapy in colorectal cancerRSC Pharmaceutics · 2026
  50. Hydrogel platforms for engineered live biotherapeutics: materials, microbial integration and clinical potentialRSC Pharmaceutics · 2026